kabutan
N225

65,020.94

+1.26%

TOPIX

4,103.23

+0.03%

USDJPY

156.36

+0.35%

Kabutan Concierge Closed Beta - Apply now

Cytori Cell Research Institute, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens

Fri Nov 14, 2025 4:00 pm JST Earnings

3750 ADR Biomedical Holdings Inc. 【J-GAAP】

Earnings Report

ADR120S,Inc. <3750> [TSE Std] announced its financial results after the market closed on November 14th (16:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) was a reduced loss of 0.13 billion yen (compared to a loss of 0.43 billion yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income/loss for the October to March period (second half) is expected to turn into a profit of 0.20 billion yen (compared to a loss of 1.70 billion yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated net loss expanded to a loss of 0.20 billion yen (compared to a loss of 0.19 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -323.1% in the same period last year to -1675.0%.

Kabutan News

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Progress Rate
vs. First Half
Announce Accounting
Standards
Apr - Sep, 2023
862M -354M -423M -443M -49.7 Nov 10, 2023 J-GAAP
Apr - Sep, 2024
91M -407M -419M -432M -48.4 Nov 14, 2024 J-GAAP
Apr - Sep, 2025
18M -332M -347M -131M -14.7 Nov 14, 2025 J-GAAP
YoY -80.2% +18.4% +17.2% +69.7% +69.7%
First Half Results vs. Previous Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Apr - Sep, 2025 Guidance 0 May 15, 2025 J-GAAP
Apr - Sep, 2025 Results 18M -332M -347M -131M -14.7 0 Nov 14, 2025 J-GAAP
Revision Rate

Current Period Guidance

Second Half Results
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Oct - Mar, 2024
31M -399M -445M -1,708M -191.3 0 May 15, 2025 J-GAAP
Guidance
Oct - Mar, 2025
1,042M 209M 209M 202M 22.6 0 Nov 14, 2025 J-GAAP
YoY +3,261.3%
Current Period Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Mar, 2024
1,560M -772M -906M 138M 15.5 0 May 14, 2024 J-GAAP
Mar, 2025
122M -806M -864M -2,140M -239.7 0 May 15, 2025 J-GAAP
Guidance
Mar, 2026
1,060M -123M -138M 71M 8.0 0 May 15, 2025 J-GAAP
YoY +768.9% +84.7% +84.0%

Quarterly Results

Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Operating
Profit Margin
Announce Accounting
Standards
Jul - Sep, 2024
52M -168M -186M -190M -21.3 -323.1% Nov 14, 2024 J-GAAP
Oct - Dec, 2024
24M -195M -217M -319M -35.8 -812.5% Feb 14, 2025 J-GAAP
Jan - Mar, 2025
7M -204M -228M -1,389M -155.6 -2,914.3% May 15, 2025 J-GAAP
Apr - Jun, 2025
6M -131M -147M 69M 7.8 -2,183.3% Aug 14, 2025 J-GAAP
Jul - Sep, 2025
12M -201M -200M -200M -22.4 -1,675.0% Nov 14, 2025 J-GAAP
YoY -76.9% -19.6% -7.5% -5.3% -5.3%